TY - JOUR
T1 - Molecular profile of the T cell receptors of regulatory and effector CD4+ T cells recognizing overlapping determinants on glutamic acid decarboxylase (524-543)
AU - Im, Jin S.
AU - Quinn, Anthony
AU - Sercarz, Eli E.
AU - Lake, Douglas F.
PY - 2004/2
Y1 - 2004/2
N2 - Glutamic acid decarboxylase (GAD65) is one of the autoantigens that initiates pathogenic T cell responses against insulin-secreting pancreatic beta cells in Type 1 diabetes (T1D). Previously it was shown that spontaneously arising pathogenic T cell responses in the NOD mouse model are confined to GAD530-543 (p530). However, regulatory T cell subpopulations, which can prevent diabetes, can also be generated, for example, by immunization with GAD524-538 (p524) or GAD524-543. Interestingly, two functionally distinct subpopulations of T cells which recognize overlapping determinants of GAD524-543, p524 and p530, utilize distinct TCR Vβ families, Vβ4 for pathogenic, and Vβ12 for regulatory T cells. We characterized T cell receptors (TCRs) from each subpopulation of T cells and visualized p524-specific TCR/p524/I-Ag7 and p530-specific TCR/p530/I-Ag7 complexes via molecular modeling to help us understand, at a molecular level, the in vivo expansion of p524- or p530-specific T cells in the NOD model of T1D. The absolute restriction in Vβ usage but not Vα usage and conserved CDR3β lengths for both T cell subpopulations demonstrates that the beta chains are main contributors in shaping both p524/I-Ag7 and p530/I-Ag7 restricted TCRs. However, only Vβ4+ T cells but not Vβ12+ T cells contain a common motif (DWG) in CDR3β and may involve all of CDR1β, CDR2β, and CDR3β in the recognition of the C-terminus of p530. These observations imply that the spontaneously arising p530-restricted TCRs may be selected under stringent structural frameworks to bind p530/I-Ag7 with high affinity. Thus, the pathogenic p530-specific T cells may arise from a small pool of autoreactive T cells upon breaking tolerance.
AB - Glutamic acid decarboxylase (GAD65) is one of the autoantigens that initiates pathogenic T cell responses against insulin-secreting pancreatic beta cells in Type 1 diabetes (T1D). Previously it was shown that spontaneously arising pathogenic T cell responses in the NOD mouse model are confined to GAD530-543 (p530). However, regulatory T cell subpopulations, which can prevent diabetes, can also be generated, for example, by immunization with GAD524-538 (p524) or GAD524-543. Interestingly, two functionally distinct subpopulations of T cells which recognize overlapping determinants of GAD524-543, p524 and p530, utilize distinct TCR Vβ families, Vβ4 for pathogenic, and Vβ12 for regulatory T cells. We characterized T cell receptors (TCRs) from each subpopulation of T cells and visualized p524-specific TCR/p524/I-Ag7 and p530-specific TCR/p530/I-Ag7 complexes via molecular modeling to help us understand, at a molecular level, the in vivo expansion of p524- or p530-specific T cells in the NOD model of T1D. The absolute restriction in Vβ usage but not Vα usage and conserved CDR3β lengths for both T cell subpopulations demonstrates that the beta chains are main contributors in shaping both p524/I-Ag7 and p530/I-Ag7 restricted TCRs. However, only Vβ4+ T cells but not Vβ12+ T cells contain a common motif (DWG) in CDR3β and may involve all of CDR1β, CDR2β, and CDR3β in the recognition of the C-terminus of p530. These observations imply that the spontaneously arising p530-restricted TCRs may be selected under stringent structural frameworks to bind p530/I-Ag7 with high affinity. Thus, the pathogenic p530-specific T cells may arise from a small pool of autoreactive T cells upon breaking tolerance.
KW - Glutamic acid decarboxylase
KW - T cell receptors
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=0347285238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347285238&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2003.09.007
DO - 10.1016/j.molimm.2003.09.007
M3 - Article
C2 - 14725793
AN - SCOPUS:0347285238
SN - 0161-5890
VL - 40
SP - 971
EP - 980
JO - Molecular Immunology
JF - Molecular Immunology
IS - 13
ER -